A number of speech disorders including stuttering have been shown to have important genetic contributions, as indicated by high heritability estimates from twin and other studies. We studied the potential contribution to stuttering from variants in the FOXP2 gene, which have previously been associated with developmental verbal dyspraxia, and from variants in the CNTNAP2 gene, which have been associated with specific language impairment (SLI). DNA sequence analysis of these two genes in a group of 602 unrelated cases, all with familial persistent developmental stuttering, revealed no excess of potentially deleterious coding sequence variants in the cases compared to a matched group of 487 well characterized neurologically normal controls. This was compared to the distribution of variants in the GNPTAB, GNPTG, and NAGPA genes which have previously been associated with persistent stuttering. Using an expanded subject data set, we again found that NAGPA showed significantly different mutation frequencies in North Americans of European descent (p = 0.0091) and a significant difference existed in the mutation frequency of GNPTAB in Brazilians (p = 0.00050). No significant differences in mutation frequency in the FOXP2 and CNTNAP2 genes were observed between cases and controls. To examine the pattern of expression of these five genes in the human brain, real time quantitative reverse transcription PCR was performed on RNA purified from 27 different human brain regions. The expression patterns of FOXP2 and CNTNAP2 were generally different from those of GNPTAB, GNPTG and NAPGA in terms of relatively lower expression in the cerebellum. This study provides an improved estimate of the contribution of mutations in GNPTAB, GNPTG and NAGPA to persistent stuttering, and suggests that variants in FOXP2 and CNTNAP2 are not involved in the genesis of familial persistent stuttering. This, together with the different brain expression patterns of GNPTAB, GNPTG, and NAGPA compared to that of FOXP2 and CNTNAP2, suggests that the genetic neuropathological origins of stuttering differ from those of verbal dyspraxia and SLI.
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Introduction
Developmental stuttering is a common, highly heritable speech disorder of children that can persist into adulthood (Gordon, 2002) . Genetic linkage studies in families have identified a number of loci for persistent stuttering (Raza et al., 2010 (Raza et al., , 2012 Riaz et al., 2005) , which in turn have led to the discovery of mutations in the GNPTAB, GNPTG, and NAGPA genes that are associated with persistent stuttering in multiple populations (Kang et al., 2010) . Developmental verbal dyspraxia is another speech disorder that can be highly heritable, and mutations in the FOXP2 gene have been associated with familial and sporadic cases (Fisher et al., 1998; Lai et al., 2001; MacDermot et al., 2005) . Specific language impairment (SLI) is a third heritable communication disorder, characterized by impairment in the acquisition of speech in otherwise normal children (Bishop, 2001) . Variants in the CNTNAP2 gene have been associated with SLI in both family and population studies (Newbury et al., 2010) . While stuttering, verbal dyspraxia, and SLI are traditionally viewed as three different disorders, they have several features in common. All three are highly heritable and are more common in males than in females. Several speech pathologies, such as word repetition and problems generating the desired speech sounds and syllables, are seen in both stuttering and dyspraxia (Kent, 2000) . Humanization of the FOXP2 gene in mouse affects the cortico-basal ganglia, parts of the human brain proposed to be involved in stuttering (Enard et al., 2009 ). Finally, FOXP2 encodes a transcription factor that has been shown to control the expression of the CNTNAP2 gene (Vernes et al., 2008) .
Identifiable mutations in the currently known genes explain only a fraction of cases for these disorders. Given the large fraction of cases Neurobiology of Disease 69 (2014) 23-31 
